A brief report on stable disease among amivantamab-treated patients with post-platinum epidermal growth factor receptor exon 20 insertion–mutated non-small cell lung cancer: A response-based analysis from the CHRYSALIS study

Nicolas Girard, Keunchil Park, Se-Hoon Lee, Santiago Viteri, Claudio A. Schioppa, Joris Diels, Mustafa Oguz, Bernardo H. Rodrigues, Nora Rahhali, Jan Sermon, Francesca Ghilotti, Tracy Li, Meena Thayu, Roland E. Knoblauch, Parthiv Mahadevia, Byoung Chul Cho

Open source

DOI: 10.1016/j.ctarc.2024.100832
Published: 2024
Container: Cancer Treatment and Research Communications
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ctarc.2024.100832,
  title = {A brief report on stable disease among amivantamab-treated patients with post-platinum epidermal growth factor receptor exon 20 insertion–mutated non-small cell lung cancer: A response-based analysis from the CHRYSALIS study},
  author = {Nicolas Girard and Keunchil Park and Se-Hoon Lee and Santiago Viteri and Claudio A. Schioppa and Joris Diels and Mustafa Oguz and Bernardo H. Rodrigues and Nora Rahhali and Jan Sermon and Francesca Ghilotti and Tracy Li and Meena Thayu and Roland E. Knoblauch and Parthiv Mahadevia and Byoung Chul Cho},
  year = {2024},
  journal = {Cancer Treatment and Research Communications},
  doi = {10.1016/j.ctarc.2024.100832},
  url = {https://doi.org/10.1016/j.ctarc.2024.100832}
}

RIS

TY  - JOUR
TI  - A brief report on stable disease among amivantamab-treated patients with post-platinum epidermal growth factor receptor exon 20 insertion–mutated non-small cell lung cancer: A response-based analysis from the CHRYSALIS study
AU  - Nicolas Girard
AU  - Keunchil Park
AU  - Se-Hoon Lee
AU  - Santiago Viteri
AU  - Claudio A. Schioppa
AU  - Joris Diels
AU  - Mustafa Oguz
AU  - Bernardo H. Rodrigues
AU  - Nora Rahhali
AU  - Jan Sermon
AU  - Francesca Ghilotti
AU  - Tracy Li
AU  - Meena Thayu
AU  - Roland E. Knoblauch
AU  - Parthiv Mahadevia
AU  - Byoung Chul Cho
PY  - 2024
JO  - Cancer Treatment and Research Communications
DO  - 10.1016/j.ctarc.2024.100832
UR  - https://doi.org/10.1016/j.ctarc.2024.100832
ER  -

APA

Girard, N., Park, K., Lee, S., Viteri, S., Schioppa, C. A., Diels, J., Oguz, M., Rodrigues, B. H., Rahhali, N., Sermon, J., Ghilotti, F., Li, T., Thayu, M., Knoblauch, R. E., Mahadevia, P., & Cho, B. C. (2024). A brief report on stable disease among amivantamab-treated patients with post-platinum epidermal growth factor receptor exon 20 insertion–mutated non-small cell lung cancer: A response-based analysis from the CHRYSALIS study. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2024.100832

Source records

crossref · retrieved 2026-09-26T22:55:59.214Z